The Manufacturers Life Insurance Company raised its position in shares of BrightSpring Health Services, Inc. (NASDAQ:BTSG - Free Report) by 7.7% in the 4th quarter, according to the company in its most recent disclosure with the SEC. The fund owned 211,361 shares of the company's stock after buying an additional 15,154 shares during the quarter. The Manufacturers Life Insurance Company owned about 0.12% of BrightSpring Health Services worth $3,599,000 at the end of the most recent reporting period.
Other hedge funds have also modified their holdings of the company. Quarry LP purchased a new position in BrightSpring Health Services during the 4th quarter worth approximately $29,000. Voya Investment Management LLC raised its position in BrightSpring Health Services by 931.8% during the 4th quarter. Voya Investment Management LLC now owns 183,277 shares of the company's stock worth $3,121,000 after buying an additional 165,515 shares during the last quarter. T. Rowe Price Investment Management Inc. purchased a new position in BrightSpring Health Services during the 4th quarter worth approximately $26,958,000. Price T Rowe Associates Inc. MD increased its holdings in shares of BrightSpring Health Services by 13.9% during the 4th quarter. Price T Rowe Associates Inc. MD now owns 2,698,629 shares of the company's stock valued at $45,959,000 after purchasing an additional 328,977 shares in the last quarter. Finally, MetLife Investment Management LLC increased its holdings in shares of BrightSpring Health Services by 4.9% during the 4th quarter. MetLife Investment Management LLC now owns 33,117 shares of the company's stock valued at $564,000 after purchasing an additional 1,548 shares in the last quarter.
Analysts Set New Price Targets
BTSG has been the subject of several recent research reports. Mizuho set a $26.00 target price on shares of BrightSpring Health Services in a report on Monday, May 5th. UBS Group lifted their target price on shares of BrightSpring Health Services from $22.00 to $30.00 and gave the company a "buy" rating in a report on Wednesday, January 29th. Finally, Morgan Stanley lifted their price target on shares of BrightSpring Health Services from $20.00 to $25.00 and gave the company an "overweight" rating in a research note on Friday. One research analyst has rated the stock with a hold rating and nine have given a buy rating to the company's stock. According to MarketBeat, the company presently has an average rating of "Moderate Buy" and an average price target of $22.89.
Get Our Latest Report on BTSG
BrightSpring Health Services Trading Down 2.1%
Shares of BTSG stock traded down $0.47 on Monday, hitting $22.35. 3,060,502 shares of the stock traded hands, compared to its average volume of 1,382,818. The firm's 50-day moving average price is $17.96 and its two-hundred day moving average price is $18.74. The company has a debt-to-equity ratio of 1.63, a quick ratio of 0.97 and a current ratio of 1.35. The stock has a market capitalization of $3.89 billion, a PE ratio of -85.96 and a beta of 2.06. BrightSpring Health Services, Inc. has a twelve month low of $10.15 and a twelve month high of $24.82.
BrightSpring Health Services (NASDAQ:BTSG - Get Free Report) last issued its quarterly earnings data on Friday, May 2nd. The company reported $0.19 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.09 by $0.10. The firm had revenue of $2.88 billion for the quarter, compared to analyst estimates of $2.74 billion. BrightSpring Health Services had a negative net margin of 0.38% and a positive return on equity of 4.16%. BrightSpring Health Services's revenue was up 25.9% on a year-over-year basis. During the same period in the previous year, the firm earned $0.12 EPS. As a group, analysts anticipate that BrightSpring Health Services, Inc. will post 0.59 EPS for the current year.
BrightSpring Health Services Company Profile
(
Free Report)
BrightSpring Health Services, Inc operates a home and community-based healthcare services platform in the United States. The company's platform focuses on delivering pharmacy and provider services, including clinical and supportive care in home and community settings to Medicare, Medicaid, and insured populations.
Further Reading

Before you consider BrightSpring Health Services, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and BrightSpring Health Services wasn't on the list.
While BrightSpring Health Services currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Wondering where to start (or end) with AI stocks? These 10 simple stocks can help investors build long-term wealth as artificial intelligence continues to grow into the future.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.